Comparison between RFA with PEI in the Treatment of Small HCC: A Systematic Review

ZHOU Quan-bo,CHEN Ru-fu,LI Zhi-hua,GUO Shuang-shuang,ZHOU Jia-jia,LIN Qing,ZHONG Feng,CHEN Ji-sheng,WANG Jie

DOI: https://doi.org/10.3969/j.issn.1671-5144.2006.04.008

2006-01-01

Abstract:Objective To evaluate the effectiveness of radio-frequency thermal ablation (RFA) in the treatment of small hepatocellular carcinoma (HCC) in patients with cirrhosis when compared with percutaneous ethanol injection (PEI). Methods We searched MEDLINE(1966-2005), EMBASE(1989-2005),The Cochrane Library(Issue 1,2005), www. controlled-trials.com, and Chinese Biomedicine Database(1980-2005). The quality evaluation of studies and the data analysis followed the methods of The Cochrane Collaboration. Meta-analysis was performed by RevMan 4.2 software. Results Four randomized controlled studies met the inclusion criteria. The results of meta-ananlysis show that the 1,3-year overall survival rate and 1,3-year tumor-free survival rate were significantly higher, and the 1,3-year local recurrent rate was significantly lower in patients with small HCC > 2 cm. But there was no significant difference in the treatment of small HCC ≤ 2 cm. Conclusions The results show that RFA ablation yielded better clinical outcomes than PEI in treating small HCC > 2 cm and no difference in treating small HCC 2 cm or less.